EVA

Anti-idiotype mAb: binds the VH in combination with the VK region of LCMV ab, KL25.

rat anti-idiotype: mAb that binds the VH of the LCMV-WE neutralising ab KL25.

IgM neutralizing antibody to VSV-IND

IgM ab specific for VSV-IND; neutralising in a plaque reduction assay. ref: Fehr et al (1997) JEM 185 1785-1792

IgM antibody neutralizing for VSV-IND

anti-VSV nucleoprotein monoclonal antibody

anti-VSV nucleoprotein monoclonal antibody

LCMV neutralizing antibody, purified.

Hybridoma cell culture supernatant containing anti-CCHFV antibodies; targeted antigen: nucleocapsid protein; clone: 3E4B1; immunization antigen: recombinant NC protein, strain "IbAr 10200"

A panel of 11 samples, including eight extracts from phylogroup 2 & 3 lyssaviruses, RABV and two NTC's (no tissue control). The panel can be anonymised so that the laboratory does not know which RNA comes from which virus. Results will be given to the requesting laboratory on request. The panel would be good for test development and assessing staff competence. RNA from the following viruses will be included: Rabies virus, Lleida Bat Lyssavirus, Ikoma virus, Shimoni Bat virus, Mokola virus and Lagos Bat Lyssaviruses a, b, c & d.

A panel of 12 samples, including 10 RNA extract from different phylogroup 1 lyssaviruses and two NTC's (no tissue controls). The panel can be anonymised so that the receiving laboratory does not know which virus is which, results given to the receiving laboratory on request.

Hybridoma cell culture supernatant containing anti-FMDVV antibodies; targeted antigen: 3A; clone: 8H8a; immunization antigen: recombinant non-structural protein 3ABC

Hybridoma cell culture supernatant containing anti-FMDVV antibodies; targeted antigen: 3B or C; clone: 9F2; immunization antigen: recombinant non-structural protein 3ABC

Hybridoma cell culture supernatant containing anti-PEDV antibodies; targeted antigen: spike protein; clone: 4H4B1; immunization antigen: PEDV strain "CV777"; IgG subtype: IgG2a

Hybridoma cell culture supernatant containing anti-PEDV antibodies; targeted antigen: matrix protein; clone: 2C3B2 ; immunization antigen: PEDV strain "CV777"; IgG subtype: IgG2b

Hybridoma cell culture supernatant containing anti-PEDV antibodies; targeted antigen: NP; clone: 1B6A3 ; immunization antigen: PEDV strain "CV777"; IgG subtype: IgG2b

Mouse monoclonal antibody against Zaïre Ebolavirus glycoprotein obtained in Balb/c mouse

A panel of 8 samples, including six RNA extracts from different rabies isolates and two NTC's (no tissue control). The source of the rabies isolates can be modified to meet individual needs, area/region isolated from, host species, etc. Also, the panel can be anonymised so that the receiving laboratory does not know which samples are positive and negative, the results will be given on request from the lab. The panel would be ideal for testing staff competence and proficiency.

RNA from Lagos Bat Virus, RV3383, in HPLC water

Viral RNA extracted from infected cell culture lysate.

Viral RNA extracted from infected cell culture lysate.

rabbit polyclonal antiserum against the pre-membrane protein (prM) of ZIKV

rabbit polyclonal antiserum against the envelop protein (prM) of ZIKV

Anti-European Bat Lyssavirus type 2, polyconal sera. Heat inactivated (56 degrees for 30 minutes). Raised in rabbits using beta-propiolactone inactivated tissue culture supernatant.

Hybridoma cell culture supernatant containing anti-CyHV-3 antibodies; targeted antigen: Orf149; IgG subtype: IgG1 κ; clone:11A4; immunization antigen: inactivated strain "KHV 41/43 (Israel)"